Clinical Trials Logo

Impulsive Behavior clinical trials

View clinical trials related to Impulsive Behavior.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05073679 Terminated - Eating Disorders Clinical Trials

Oral Naltrexone In Pediatric Eating Disorders

ONPED
Start date: April 22, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to evaluate the effectiveness of oral naltrexone tablets in pediatric and adolescent eating disorders, in particular anorexia nervosa and bulimia nervosa, as compared to placebo. Study participants will be patients in a partial hospitalization program or intensive outpatient program for eating disorder.

NCT ID: NCT04781166 Terminated - Suicidal Ideation Clinical Trials

An Online Intervention to Reduce Self-Harm Among Persons With High Emotion-Related Impulsivity

Start date: April 15, 2021
Phase: N/A
Study type: Interventional

The goal of this program is to test a brief, online, cognitive behavioral intervention for people who struggle with self-harm or suicidal urges or behavior in the context of emotion-related impulsivity.

NCT ID: NCT03838484 Terminated - Schizophrenia Clinical Trials

Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia

Start date: May 10, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to test whether nicotine, a drug that activates receptors called nicotinic acetylcholine receptors in the brain, improves the ability to make or withhold responses to faces that are either emotionally neutral or emotionally negative. This study will also test whether the drug affects brain activity while making or withholding responses using electroencephalography. Previous studies in people with schizophrenia have shown that more errors in response to negative emotional cues are related to greater likelihood of impulsive aggressive behavior. Therefore, the aim of this study is to determine whether nicotine might be a new strategy to reduce aggressive behavior. The investigators' goal is 25 individuals with schizophrenia and 25 healthy controls to complete the study at Vanderbilt.

NCT ID: NCT03638466 Terminated - Clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)

Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder

Start date: May 30, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of 4-week SPN-810 treatment on brain functioning in patients aged 8-12 years with ADHD and associated feature of impulsive aggression (IA). This will be achieved using functional magnetic resonance imaging (fMRI) in conjunction with the point subtraction aggression paradigm (PSAP) Task, a behavioral aggression paradigm in which subjects are provoked by having money indirectly taken from them by a fictitious opponent, simulating an aggression response.

NCT ID: NCT03527550 Terminated - Mental Disorders Clinical Trials

Cognitive Control Training for Urgency in a Naturalistic Clinical Setting

Start date: September 11, 2018
Phase: N/A
Study type: Interventional

This study is designed to test whether computer-based cognitive exercises are helpful for reducing a specific type of impulsivity. Also, the study is testing whether these are exercises are associated with specific changes in behavior and in the brain. Participants will be psychiatric patients enrolled in a partial hospitalization program. Half of these participants will receive usual treatment, and half will complete computer-based cognitive exercises in addition to usual treatment.